The aryl hydrocarbon receptor ligands 2,3,7,8-tetrachlorodibenzo-p-dioxin and 3-methylcholanthrene regulate distinct genetic networks

Molecular and Cellular Endocrinology

Volumn 362, Issue 1-2, 2012, Pages 39-47

  Swedenborg, Elin ^a   Kotka, Maria ^a   Seifert, Martin ^b   Kanno, Jun ^c   Pongratz, Ingemar ^a   Rüegg, Joëlle ^d  

^a KAROLINSKA INSTITUTE   (Sweden)

^b Genomatix GmbH   (Germany)

^c NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

^d UNIVERSITY OF BASEL   (Switzerland)

Author keywords

3 Methylcholanthrene; Arylhydrocarbon receptor; Dioxin; Endocrine disruption; Estrogen receptor

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; 3 METHYLCHOLANTHRENE; AROMATIC HYDROCARBON RECEPTOR; DIETHYLSTILBESTROL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA;

ALDH3A1 GENE; AQP3 GENE; ARTICLE; ATF3 GENE; C5AR1 GENE; CCL20 GENE; CDKN1A GENE; CELL STRAIN HEPG2; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; CYP1A1 GENE; CYP4F11 GENE; DRUG EXPOSURE; EGR1 GENE; FOXJ1 GENE; FST GENE; GDF15 GENE; GENE; GENE CONTROL; GENE EXPRESSION PROFILING; GENE REGULATORY NETWORK; GPR77 GENE; HUMAN; HUMAN CELL; IGF2 GENE; IL11 GENE; MICROARRAY ANALYSIS; MLPH GENE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; REAL TIME POLYMERASE CHAIN REACTION; SERPINE1 GENE; SIGNAL TRANSDUCTION; SLC7A11 GENE; SMOX GENE; TSPAN7 GENE; UPREGULATION;

CHROMATIN IMMUNOPRECIPITATION; ENDOCRINE DISRUPTORS; ESTROGEN RECEPTOR ALPHA; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORKS; GENES; HEP G2 CELLS; HUMANS; METHYLCHOLANTHRENE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, ARYL HYDROCARBON; TETRACHLORODIBENZODIOXIN; TRANSCRIPTIONAL ACTIVATION; TRANSCRIPTOME;

EID: 84865297172     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2012.05.006     Document Type: Article

References (56)

1. Abdelrahim M., Ariazi E., Kim K., Khan S., Barhoumi R., Burghardt R., Liu S., Hill D., Finnell R., Wlodarczyk B., Jordan V.C., Safe S. 3-Methylcholanthrene and other aryl hydrocarbon receptor agonists directly activate estrogen receptor alpha. Cancer Res. 2006, 66:2459-2467.
2. Abdelrahim M., Smith R., Safe S. Aryl hydrocarbon receptor gene silencing with small inhibitory RNA differentially modulates Ah-responsiveness in MCF-7 and HepG2 cancer cells. Mol. Pharmacol. 2003, 63:1373-1381.
3. Astroff B., Safe S. 2,3,7,8-Tetrachlorodibenzo-p-dioxin as an antiestrogen: effect on rat uterine peroxidase activity. Biochem. Pharmacol. 1990, 39:485-488.
4. Barkhem T., Andersson-Ross C., Hoglund M., Nilsson S. Characterization of the "estrogenicity" of tamoxifen and raloxifene in HepG2 cells: regulation of gene expression from an ERE controlled reporter vector versus regulation of the endogenous SHBG and PS2 genes. J. Steroid Biochem. Mol. Biol. 1997, 62:53-64.
5. Barros R.P., Gustafsson J.A. Estrogen receptors and the metabolic network. Cell Metab. 2011, 14:289-299.
6. Bourdeau V., Deschenes J., Metivier R., Nagai Y., Nguyen D., Bretschneider N., Gannon F., White J.H., Mader S. Genome-wide identification of high-affinity estrogen response elements in human and mouse. Mol. Endocrinol. 2004, 18:1411-1427.
7. Boverhof D.R., Burgoon L.D., Williams K.J., Zacharewski T.R. Inhibition of estrogen-mediated uterine gene expression responses by dioxin. Mol. Pharmacol. 2008, 73:82-93.
8. Brunnberg S., Pettersson K., Rydin E., Matthews J., Hanberg A., Pongratz I. The basic helix-loop-helix-PAS protein ARNT functions as a potent coactivator of estrogen receptor-dependent transcription. Proc. Natl. Acad Sci. USA 2003, 100:6517-6522.
9. Burchiel S.W., Thompson T.A., Lauer F.T., Oprea T.I. Activation of dioxin response element (DRE)-associated genes by benzo(a)pyrene 3,6-quinone and benzo(a)pyrene 1,6-quinone in MCF-10A human mammary epithelial cells. Toxicol. Appl. Pharmacol. 2007, 221:203-214.
10. Burdette J.E., Woodruff T.K. Activin and estrogen crosstalk regulates transcription in human breast cancer cells. Endocr. Relat. Cancer 2007, 14:679-689.
11. Bursztyka J., Perdu E., Pettersson K., Pongratz I., Fernandez-Cabrera M., Olea N., Debrauwer L., Zalko D., Cravedi J.P. Biotransformation of genistein and bisphenol A in cell lines used for screening endocrine disruptors. Toxicol. In Vitro 2008, 22:1595-1604.
12. Chaloupka K., Krishnan V., Safe S. Polynuclear aromatic hydrocarbon carcinogens as antiestrogens in MCF-7 human breast cancer cells: role of the Ah receptor. Carcinogenesis 1992, 13:2233-2239.
13. Charles G.D., Bartels M.J., Zacharewski T.R., Gollapudi B.B., Freshour N.L., Carney E.W. Activity of benzo[a]pyrene and its hydroxylated metabolites in an estrogen receptor-alpha reporter gene assay. Toxicol. Sci. 2000, 55:320-326.
14. de Kretser D.M., Hedger M.P., Loveland K.L., Phillips D.J. Inhibins, activins and follistatin in reproduction. Hum. Reprod. Update 2002, 8:529-541.
15. Denger S., Bahr-Ivacevic T., Brand H., Reid G., Blake J., Seifert M., Lin C.Y., May K., Benes V., Liu E.T., Gannon F. Transcriptome profiling of estrogen-regulated genes in human primary osteoblasts reveals an osteoblast-specific regulation of the insulin-like growth factor binding protein 4 gene. Mol. Endocrinol. 2008, 22:361-379.
16. Elobeid M.A., Allison D.B. Putative environmental-endocrine disruptors and obesity: a review. Curr. Opin. Endocrinol. Diabetes Obes. 2008, 15:403-408.
17. Gozgit J.M., Nestor K.M., Fasco M.J., Pentecost B.T., Arcaro K.F. Differential action of polycyclic aromatic hydrocarbons on endogenous estrogen-responsive genes and on a transfected estrogen-responsive reporter in MCF-7 cells. Toxicol. Appl. Pharmacol. 2004, 196:58-67.
18. Harper N., Wang X., Liu H., Safe S. Inhibition of estrogen-induced progesterone receptor in MCF-7 human breast cancer cells by aryl hydrocarbon (Ah) receptor agonists. Mol. Cell Endocrinol. 1994, 104:47-55.
19. Huang G., Elferink C.J. A novel non-consensus xenobiotic response element capable of mediating aryl hydrocarbon receptor dependent gene expression. Mol. Pharmacol. 2011.
20. Iseki M., Ikuta T., Kobayashi T., Kawajiri K. Growth suppression of Leydig TM3 cells mediated by aryl hydrocarbon receptor. Biochem. Biophys. Res. Commun. 2005, 331:902-908.
21. Kanno J., Aisaki K., Igarashi K., Nakatsu N., Ono A., Kodama Y., Nagao T. "Per cell" normalization method for mRNA measurement by quantitative PCR and microarrays. BMC Genom. 2006, 7:64.
22. Kharat I., Saatcioglu F. Antiestrogenic effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin are mediated by direct transcriptional interference with the liganded estrogen receptor. Cross-talk between aryl hydrocarbon- and estrogen-mediated signaling. J. Biol. Chem. 1996, 271:10533-10537.
23. Klinge C.M., Kaur K., Swanson H.I. The aryl hydrocarbon receptor interacts with estrogen receptor alpha and orphan receptors COUP-TFI and ERRalpha1. Arch. Biochem. Biophys. 2000, 373:163-174.
24. Liu S., Abdelrahim M., Khan S., Ariazi E., Jordan V.C., Safe S. Aryl hydrocarbon receptor agonists directly activate estrogen receptor alpha in MCF-7 breast cancer cells. Biol. Chem. 2006, 387:1209-1213.
25. Mandal S., Davie J.R. Estrogen regulated expression of the p21 Waf1/Cip1 gene in estrogen receptor positive human breast cancer cells. J. Cell Physiol. 2010, 224:28-32.
26. Matthews J., Wihlen B., Thomsen J., Gustafsson J.A. Aryl hydrocarbon receptor-mediated transcription: ligand-dependent recruitment of estrogen receptor alpha to 2,3,7,8-tetrachlorodibenzo-p-dioxin-responsive promoters. Mol. Cell Biol. 2005, 25:5317-5328.
27. Matzuk M.M., Lu N., Vogel H., Sellheyer K., Roop D.R., Bradley A. Multiple defects and perinatal death in mice deficient in follistatin. Nature 1995, 374:360-363.
28. Metivier R., Penot G., Hubner M.R., Reid G., Brand H., Kos M., Gannon F. Estrogen receptor-alpha directs ordered, cyclical, and combinatorial recruitment of cofactors on a natural target promoter. Cell 2003, 115:751-763.
29. Moller F.J., Diel P., Zierau O., Hertrampf T., Maass J., Vollmer G. Long-term dietary isoflavone exposure enhances estrogen sensitivity of rat uterine responsiveness mediated through estrogen receptor alpha. Toxicol. Lett. 2010, 196:142-153.
30. Mukherjee S., Koner B.C., Ray S., Ray A. Environmental contaminants in pathogenesis of breast cancer. Indian J. Exp. Biol. 2006, 44:597-617.
31. Newbold R.R., Padilla-Banks E., Jefferson W.N., Heindel J.J. Effects of endocrine disruptors on obesity. Int. J. Androl. 2008, 31:201-208.
32. Nilsson S., Makela S., Treuter E., Tujague M., Thomsen J., Andersson G., Enmark E., Pettersson K., Warner M., Gustafsson J.A. Mechanisms of estrogen action. Physiol. Rev. 2001, 81:1535-1565.
33. Nomura T. Transgenerational effects from exposure to environmental toxic substances. Mutat. Res. 2008, 659:185-193.
34. Pang P.H., Lin Y.H., Lee Y.H., Hou H.H., Hsu S.P., Juan S.H. Molecular mechanisms of p21 and p27 induction by 3-methylcholanthrene, an aryl-hydrocarbon receptor agonist, involved in antiproliferation of human umbilical vascular endothelial cells. J. Cell Physiol. 2008, 215:161-171.
35. Pathak S., D'Souza R., Ankolkar M., Gaonkar R., Balasinor N.H. Potential role of estrogen in regulation of the insulin-like growth factor2-H19 locus in the rat testis. Mol. Cell Endocrinol. 2010, 314:110-117.
36. Poland A., Knutson J.C. 2,3,7,8-Tetrachlorodibenzo-p-dioxin and related halogenated aromatic hydrocarbons: examination of the mechanism of toxicity. Annu. Rev. Pharmacol. Toxicol. 1982, 22:517-554.
37. Puga A., Barnes S.J., Chang C., Zhu H., Nephew K.P., Khan S.A., Shertzer H.G. Activation of transcription factors activator protein-1 and nuclear factor-kappaB by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Biochem. Pharmacol. 2000, 59:997-1005.
38. Riu A., Grimaldi M., le Maire A., Bey G., Phillips K., Boulahtouf A., Perdu E., Zalko D., Bourguet W., Balaguer P. Peroxisome proliferator-activated receptor gamma is a target for halogenated analogs of bisphenol A. Environ. Health Perspect. 2011, 119:1227-1232.
39. Ruegg J., Penttinen-Damdimopoulou P., Makela S., Pongratz I., Gustafsson J.A. Receptors mediating toxicity and their involvement in endocrine disruption. EXS 2009, 99:289-323.
40. Ruegg J., Swedenborg E., Wahlstrom D., Escande A., Balaguer P., Pettersson K., Pongratz I. The transcription factor aryl hydrocarbon receptor nuclear translocator functions as an estrogen receptor beta-selective coactivator, and its recruitment to alternative pathways mediates antiestrogenic effects of dioxin. Mol. Endocrinol. 2008, 22:304-316.
41. Safe S., McDougal A. Mechanism of action and development of selective aryl hydrocarbon receptor modulators for treatment of hormone-dependent cancers (review). Int. J. Oncol. 2002, 20:1123-1128.
42. Safe S., Wormke M. Inhibitory aryl hydrocarbon receptor-estrogen receptor alpha cross-talk and mechanisms of action. Chem. Res. Toxicol. 2003, 16:807-816.
43. Safe S., Wormke M., Samudio I. Mechanisms of inhibitory aryl hydrocarbon receptor-estrogen receptor crosstalk in human breast cancer cells. J. Mammary Gland Biol. Neoplasia 2000, 5:295-306.
44. Sladek N.E. Transient induction of increased aldehyde dehydrogenase 3A1 levels in cultured human breast (adeno)carcinoma cell lines via 5'-upstream xenobiotic, and electrophile, responsive elements is, respectively, estrogen receptor-dependent and -independent. Chem. Biol. Interact. 2003, 143-144:63-74.
45. Spink D.C., Katz B.H., Hussain M.M., Pentecost B.T., Cao Z., Spink B.C. Estrogen regulates Ah responsiveness in MCF-7 breast cancer cells. Carcinogenesis 2003, 24:1941-1950.
46. Swedenborg E., Ruegg J., Hillenweck A., Rehnmark S., Faulds M.H., Zalko D., Pongratz I., Pettersson K. 3-Methylcholanthrene displays dual effects on estrogen receptor (ER) alpha and ER beta signaling in a cell-type specific fashion. Mol. Pharmacol. 2008, 73:575-586.
47. Swedenborg E., Ruegg J., Makela S., Pongratz I. Endocrine disruptive chemicals: mechanisms of action and involvement in metabolic disorders. J. Mol. Endocrinol. 2009.
48. Szabo P.E., Pfeifer G.P., Mann J.R. Parent-of-origin-specific binding of nuclear hormone receptor complexes in the H19-Igf2 imprinting control region, Mol. Cell Biol. 2004, 24:4858-4868.
49. Thomas T.J., Faaland C.A., Adhikarakunnathu S., Watkins L.F., Thomas T. Induction of p21 (CIP1/WAF1/SID1) by estradiol in a breast epithelial cell line transfected with the recombinant estrogen receptor gene: a possible mechanism for a negative regulatory role of estradiol. Breast Cancer Res. Treat. 1998, 47:181-193.
50. Vasiliou V., Reuter S.F., Williams S., Puga A., Nebert D.W. Mouse cytosolic class 3 aldehyde dehydrogenase (Aldh3a1): gene structure and regulation of constitutive and dioxin-inducible expression. Pharmacogenetics 1999, 9:569-580.
51. Vidaeff A.C., Sever L.E. In utero exposure to environmental estrogens and male reproductive health: a systematic review of biological and epidemiologic evidence. Reprod. Toxicol. 2005, 20:5-20.
52. Wang F., Samudio I., Safe S. Transcriptional activation of cathepsin D gene expression by 17beta-estradiol: mechanism of aryl hydrocarbon receptor-mediated inhibition. Mol. Cell Endocrinol. 2001, 172:91-103.
53. Whitlock J.P. Induction of cytochrome P4501A1. Annu. Rev. Pharmacol. Toxicol. 1999, 39:103-125.
54. Wood A.W., Chang R.L., Levin W., Thomas P.E., Ryan D., Stoming T.A., Thakker D.R., Jerina D.M., Conney A.H. Metabolic activation of 3-methylcholanthrene and its metabolites to products mutagenic to bacterial and mammalian cells. Cancer Res. 1978, 38:3398-3404.
55. Wormke M., Castro-Rivera E., Chen I., Safe S. Estrogen and aryl hydrocarbon receptor expression and crosstalk in human Ishikawa endometrial cancer cells. J. Steroid Biochem. Mol. Biol. 2000, 72:197-207.
56. Zacharewski T.R., Bondy K.L., McDonell P., Wu Z.F. Antiestrogenic effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin on 17 beta-estradiol-induced pS2 expression. Cancer Res. 1994, 54:2707-2713.